Adaptive Biotechnologies reviews

Extremely poor executive leadership. The founders and most of the C-Suite team have no experience in leading a biotech company and it shows. There is no consistent direction, scientifically or commercially. The lack of sticking with direction made my head spin. In particular, products would be launched and then shelved immediately. Plans for personnel moves with new facilities changed every other week. Many of the leaders in the organization were more focused on looking good and their own advancement them on their employees and what was good for the company. Talking to former colleagues, that hasn’t changed. There is also on-going “restructuring” that results in ongoing layoffs across the company. Without some serious reevaluation of the vision of the company and the capabilities, experience and competency of the leaders, this company is on track to fail fast. The company talks a lot about diversity and inclusion, but only supports the concept in a very superficial way rather than truly valuing diverse backgrounds and perspectives. The HR team talks about employee professional development but doesn’t really stand behind the employees or value the development.

Lack of experience at the highest levels, including a constant need for affirmation, has resulted in poor business decisions, poor planning and chaotic pivots from one business objective to the next.